NCT06882551

Comparison of Intravitreal Bevacizumab Injection with Combination of Suprachoroidal Triamcinolone Acetonide Along with Intravitreal Bevacizumab Injection in the Treatment of Diabetic Macular Edema in Pseudophakic Patients

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 82 (actual)
• Sponsor: Khyber Teaching Hospital · Academic / Other
• Sex: All
• Age: 32 Years – 78 Years
• Healthy volunteers: Not accepted

Summary

Patients were included in the study who were pseudophakic with center-involved (sub-foveal) diabetic macular edema

Detailed description

Patients were included in the study who were pseudophakic with center-involved (sub-foveal) diabetic macular edema. Those patients who had glaucoma history or IOP above 21 mm of Hg, Phakic, corneal opacity, vitreous hemorrhage, proliferative diabetic retinopathy, already received anti-VEGF injections, history of pan-retinal photocoagulation for proliferative diabetic retinopathy.

Conditions

• Diabetic Macular Edema (DME)

Interventions

Type	Name	Description
DRUG	Intravitreal Bevacizumab IVB	Intravitreal bevacizumab alone
DRUG	intravitreal bevacizumab and suprachoroidal triamcinolone acetonide	Combination of Intravitreal bevacizumab and suprachoroidal triamcinolone acetonide

Timeline

• Start date: 2023-04-01
• Primary completion: 2023-11-30
• Completion: 2024-01-15
• First posted: 2025-03-18
• Last updated: 2025-03-18

Locations

1 site across 1 country: Pakistan